Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Geron Corporation May 31, 202392.0%
-
BioMarin Pharmaceutical Inc. May 23, 202396.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 9, 2025 | Geron Corporation | Open-market purchase | +13,300 | $1.18 | $15,694 |
| May 15, 2024 | Geron Corporation | Option exercise | +35,000 | $1.94 | $67,900 |
| May 15, 2024 | Geron Corporation | Open-market sale | −35,000 | $3.75 | $131,250 |
| May 23, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +4,190 | — | — |
| May 11, 2023 | Geron Corporation | Option exercise | +35,000 | $1.10 | $38,500 |
| May 11, 2023 | Geron Corporation | Open-market sale | −35,000 | $3.00 | $105,000 |
| Apr 3, 2023 | BioMarin Pharmaceutical Inc. | Option exercise | +8,500 | $67.81 | $576,385 |
| Apr 3, 2023 | BioMarin Pharmaceutical Inc. | Open-market sale | −8,500 | $97.09 | $825,265 |
Questions about V. Bryan Lawlis
What boards is V. Bryan Lawlis on?
V. Bryan Lawlis sits on the boards of BioMarin Pharmaceutical Inc. and Geron Corporation.
How long has V. Bryan Lawlis served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.